Navigation Links
Not All ADHD Drugs Are Equal

Researchers at the University of Virginia Health System have found that teenage drivers with attention deficit hyper activity disorder (ADHD) drive better when they took// OROS methylphenidate (OROS MPH), a controlled-release stimulant, rather than extended release amphetamine salts (se-AMPH ER). The findings, which reinforce the use of OROS MPH to improve driving performance in teens with ADHD, will appear in the Sept. issue of Pediatrics.

“Car collisions are two to four times more likely to occur among teens with ADHD. Past studies have shown that stimulants commonly used to treat ADHD can help improve driving performance among this group,” said Daniel Cox, Ph.d., lead author and professor of psychiatric medicine at the University of Virginia Health System. “However, there are many different formulations of stimulant drugs to treat ADHD and parents need to know which ones will have the best positive effect.”

In previous studies, Cox and his team set out to determine whether immediate-release and extended release drug formulations influence driving performance throughout the day. They found that OROS MPH (Concerta) compared with immediate-release methylphenidate (Ritalin) was better at improving driving performance. The OROS technology uses osmotic pressure to deliver the drug at a controlled rate.

In this study, researchers compared Concerta to se-AMPH ER (Adderall XR). Both are long-acting stimulants used to treat ADHD. Using a driving simulator, teen drivers between 16 and 19 years of age, displayed their driving skills after taking Concerta, Adderall XR or placebo. Study participants took their medications at 8 a.m. They came to the driving simulator laboratory and completed 15-minute simulated drives at 5 p.m., 8 p.m. and 11p.m. Driving performance was determined by sophisticated computer algorithms.

Researchers found that treatments with Concerta led to fewer inattentive driving errors and less hyperactive or im pulsive driving errors, such as speeding and inappropriate braking, compared with Adderall XR and placebo.

“This was the first study of its kind to demonstrate that OROS methylphenidate has therapeutic benefits among teens for up to 15 hours,” said Cox. “We hope these results encourage teens to be vigilant in taking their medication as prescribed to help contribute to their driving safety and help them appreciate the benefits of stimulant therapy.”

“The study suggests that Concerta should be the initial treatment of choice for teen drivers with ADHD, though teens already on Adderall XR should not necessarily switch medications if they demonstrate a robust therapeutic response”, according to Cox.

In addition, accidents occur most frequently in the evenings and on weekends, meaning parents should not necessarily limit medication use to school days.

Source-Newswie
SRM
'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2017)... ... ... Reassured For Life ( http://www.reassured.ca ), is now open. , “Reassured For ... Nerissa McNaughton. “I launched this firm because I know talking about life, accident, sickness, ... I make it easy. As a broker I have access to all the life ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine managing ... available on the market," said an inventor from Center Valley, Pa. "My idea is ... patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern Georgie ... Foundation in a community wide charity event with the goal of bringing in support ... local woman who lives with epilepsy, recently launched a charity campaign of her own ...
(Date:7/21/2017)... ... 21, 2017 , ... Adolfson & Peterson Construction (AP) along ... County Medical Examiners Facility located in Saint Paul, Minn. A single story, 10,688 ... to start in late 2017/early 2018. , Staffed by 20 full-time employees ...
(Date:7/21/2017)... Connecticut (PRWEB) , ... July 21, 2017 , ... Hospital ... from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in the ... of 2017, and up 15% from the 20 announced deals in the year-ago second ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a new ... suffer from painful intercourse and other painful pelvic pain conditions such as ... menopause. ... ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void in ...
(Date:7/10/2017)... 10, 2017  BDI Group subsidiary Pathway Purchasing ... services organization serving specialty pharmacies, home infusion companies ... four significant, value-added member programs designed to help ... reimbursement and improve access and affordability for patients ... Pathway has ...
Breaking Medicine Technology: